Clinical Trial Update: Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the FiiRST study evaluating fibrinogen in initial resuscitation of severe trauma (Phase 1/Phase 2; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy
• Hemorrhage
• Traumatic Injury

Drugs mentioned

• Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Trauma, Injury | Phase 1, Phase 2 | Status: COMPLETED